Cass, I agree totally, the supply chain has been my primary concern all along. My strong contention is leronlimab will not get approval before supply is confirmed in hand and a delivery/distribution network is well established. I firmly believe the entire supply chain is part of the master plan between FDA and CYDY. The role out success is critical, they only have one chance to get it right and I suspect this plan is being reviewed at the highest levels of our government. Maybe my fanciful ideas are too ambitious for some but for me all of the hand wringing and gnashing of teeth about anything else bores me to tears. To each his own.
In the end it will all work out, Samsung can and will ramp up production yet this year if needed, AGC is all clear and producing too, and we have a new contract for aseptic vial filling and finishing of drug thru Aji Bio-Pharma.
FYI...today is the day the NEJM publishes papers.....lets hope Dr Patterson and Montefiore hospital are on the front page.